TERT and urinary bladder carcinoma: In UBC, the telomerase reverse transcriptase (TERT) promoter mutations represent the most recurrent genetic mutations, which have been identified as a significant influence in carcinogenesis development for 60%–80% of bladder cancer patients.23, 24, 25